Seeking Alpha · VSTM · October 14, 2026

Verastem, Inc. (VSTM) Discusses New Clinical Data for VS-7375 KRAS G12D Inhibitor in Pancreatic, Lung, and Colorectal Cancers Transcript

Get the app for more

Explore stock news, insights and company research.